AU2538797A - Photodynamic therapy using nuclear hormone receptors to target photosensitizers - Google Patents

Photodynamic therapy using nuclear hormone receptors to target photosensitizers

Info

Publication number
AU2538797A
AU2538797A AU25387/97A AU2538797A AU2538797A AU 2538797 A AU2538797 A AU 2538797A AU 25387/97 A AU25387/97 A AU 25387/97A AU 2538797 A AU2538797 A AU 2538797A AU 2538797 A AU2538797 A AU 2538797A
Authority
AU
Australia
Prior art keywords
photodynamic therapy
hormone receptors
nuclear hormone
photosensitizers
target
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU25387/97A
Inventor
Scott C. Mohr
Rahul Ray
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boston University
Original Assignee
Boston University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boston University filed Critical Boston University
Publication of AU2538797A publication Critical patent/AU2538797A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0071—PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
AU25387/97A 1996-03-22 1997-03-21 Photodynamic therapy using nuclear hormone receptors to target photosensitizers Abandoned AU2538797A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US1387196P 1996-03-22 1996-03-22
US60013871 1996-03-22
PCT/US1997/004542 WO1997034637A2 (en) 1996-03-22 1997-03-21 Photodynamic therapy using nuclear hormone receptors to target photosensitizers

Publications (1)

Publication Number Publication Date
AU2538797A true AU2538797A (en) 1997-10-10

Family

ID=21762233

Family Applications (1)

Application Number Title Priority Date Filing Date
AU25387/97A Abandoned AU2538797A (en) 1996-03-22 1997-03-21 Photodynamic therapy using nuclear hormone receptors to target photosensitizers

Country Status (2)

Country Link
AU (1) AU2538797A (en)
WO (1) WO1997034637A2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2375865C (en) * 1999-06-03 2009-08-18 The General Hospital Corporation Treatment and analysis of proliferative disorders
WO2005120588A2 (en) * 2004-05-26 2005-12-22 The Curators Of The University Of Missouri Peptides delivered to cell nuclei
CN108524919A (en) 2012-05-17 2018-09-14 延伸生物科学股份有限公司 carrier for improved drug delivery
JP6946182B2 (en) 2014-10-22 2021-10-06 エクステンド バイオサイエンシズ インコーポレーテッドＥｘｔｅｎｄ Ｂｉｏｓｃｉｅｎｃｅｓ， Ｉｎｃ Therapeutic Vitamin D Conjugate
US9789197B2 (en) 2014-10-22 2017-10-17 Extend Biosciences, Inc. RNAi vitamin D conjugates
WO2016065052A1 (en) 2014-10-22 2016-04-28 Extend Biosciences, Inc. Insulin vitamin d conjugates

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5457183A (en) * 1989-03-06 1995-10-10 Board Of Regents, The University Of Texas System Hydroxylated texaphyrins
AU1424492A (en) * 1991-02-20 1992-09-15 Christopher Capelli Non-protein intracellular receptor binding conjugates and a method of use thereof
US5591422A (en) * 1995-06-02 1997-01-07 Pharmacyclics, Inc. Texaphyrin complexes having improved functionalization

Also Published As

Publication number Publication date
WO1997034637A2 (en) 1997-09-25
WO1997034637A3 (en) 1998-01-29

Similar Documents

Publication Publication Date Title
AU6280298A (en) Ultrasonic alternative to laser-based photodynamic therapy
AU7474791A (en) Improved compositions for photodynamic therapy
EP0822984A4 (en) Human tumor necrosis factor receptors
PL329947A1 (en) Baloon catheter for use in photodynamic therapy
AU5590098A (en) Endoprosthetic device with therapeutic compound
AU6964496A (en) Megavoltage radiation therapy machine combined with diagnostic imaging devices
AU8428898A (en) Apparatus and methods to monitor photodynamic therapy (pdt)
AU5424596A (en) Microminiature illuminator for administering photodynamic therapy
GB2320190B (en) Total hormone replacement therapy
AU6534998A (en) Bidding for energy supply
AU1380095A (en) Device for stimulating body cells by electromagnetic radiation
AU6721598A (en) Dioxino derivatives and their use as therapeutic agents
AU6236998A (en) Infared radiation therapy device
ZA952587B (en) Human tumor necrosis factor receptor
AU4377793A (en) Alternative receptor therapy
AUPM695294A0 (en) Improved combination therapy dose unit
EP1091742A4 (en) Indium photosensitizers for pdt
AU1497897A (en) Combination therapy to treat osteoporosis
AU3118697A (en) Radiation therapy dose calculation engine
AU2538797A (en) Photodynamic therapy using nuclear hormone receptors to target photosensitizers
AU5315096A (en) 19-oxygenated steroids as therapeutic agents
AU6017198A (en) Substituted perylenequinones for use in photodynamic therapy
AU2193797A (en) Delivery of therapeutic agents to the prostate
AU1171099A (en) Therapeutic agents
GB9703633D0 (en) Cancer therapy